In all, 331 men were identified from this group as potential controls after exclusion of men <50 years old with either a history of bladder or prostate cancer, cancer identified during investigation or a positive NMP22 result (>7 U ml–1). The gene discussed is NUMA1; the disease is prostate carcinoma.